<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37399124</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Impact of the Affordable Care Act on Providing Equitable Healthcare Access for IBD in the Kentucky Appalachian Region.</ArticleTitle><Pagination><StartPage>1273</StartPage><EndPage>1281</EndPage><MedlinePgn>1273-1281</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000002942</ELocationID><Abstract><AbstractText Label="BACKGROUND">Medicaid expansion improved insurance coverage for patients with chronic conditions and low income. The effect of Medicaid expansion on patients with IBD from high-poverty communities is unknown.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to evaluate the impact of Medicaid expansion in Kentucky on care for patients with IBD from the Eastern Kentucky Appalachian community, a historically impoverished area.</AbstractText><AbstractText Label="DESIGN">This study was a retrospective, descriptive, and ecological study.</AbstractText><AbstractText Label="SETTINGS">This study was conducted in Kentucky using the Hospital Inpatient Discharge and Outpatient Services Database.</AbstractText><AbstractText Label="PATIENTS">All encounters for IBD care for 2009-2020 for patients from the Eastern Kentucky Appalachian region were included.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcomes measured were proportions of inpatient and emergency encounters, total hospital charge, and hospital length of stay.</AbstractText><AbstractText Label="RESULTS">Eight hundred twenty-five preexpansion and 5726 postexpansion encounters were identified. Postexpansion demonstrated decreases in the uninsured (9.2%-1.0%; p &lt; 0.001), inpatient encounters (42.7%-8.1%; p &lt; 0.001), emergency admissions (36.7%-12.3%; p &lt; 0.001), admissions from the emergency department (8.0%-0.2%; p &lt; 0.001), median total hospital charge ($7080-$3260; p &lt; 0.001), and median total hospital length of stay (4-3 days; p &lt; 0.001). Similarly, postexpansion demonstrated increases in Medicaid coverage (18.8%-27.7%; p &lt; 0.001), outpatient encounters (57.3%-91.9%; p &lt; 0.001), elective admissions (46.9%-76.2%; p &lt; 0.001), admissions from the clinic (78.4%-90.2%; p &lt; 0.001), and discharges to home (43.8%-88.2%; p &lt; 0.001).</AbstractText><AbstractText Label="LIMITATIONS">This study is subject to the limitations inherent in being retrospective and using a partially de-identified database.</AbstractText><AbstractText Label="CONCLUSION">This study is the first to demonstrate the changes in trends in care after Medicaid expansion for patients with IBD in the Commonwealth of Kentucky, especially Appalachian Kentucky, showing significantly increased outpatient care utilization, reduced emergency department encounters, and decreased length of stays.</AbstractText><AbstractText Label="IMPACTO DE LA LEY DEL CUIDADO DE SALUD A BAJO PRECIO EN LA PROVISIN DE ACCESO EQUITATIVO A LA ATENCIN MDICA PARA LA ENFERMEDAD INFLAMATORIA INTESTINAL EN LA REGIN DE LOS APALACHES DE KENTUCKY">ANTECEDENTES: La expansi&#xf3;n de Medicaid mejor&#xf3; la cobertura de seguro para pacientes con enfermedades cr&#xf3;nicas y bajos ingresos. Se desconoce el efecto de la expansi&#xf3;n de Medicaid en pacientes con enfermedad inflamatoria intestinal de comunidades de alta pobreza.OBJETIVO: Este estudio tuvo como objetivo evaluar el impacto de la expansi&#xf3;n de Medicaid en Kentucky en la atenci&#xf3;n de pacientes con enfermedad inflamatoria intestinal de la comunidad de los Apalaches del este de Kentucky, un &#xe1;rea hist&#xf3;ricamente empobrecida.DISE&#xd1;O: Este estudio fue un estudio retrospectivo, descriptivo, ecol&#xf3;gico.ESCENARIO: Este estudio se realiz&#xf3; en Kentucky utilizando la base de datos de servicios ambulatorios y de alta hospitalaria en pacientes hospitalizados.PACIENTES: Se incluyeron todos los encuentros para la atenci&#xf3;n de la enfermedad inflamatoria intestinal de 2009-2020 para pacientes de la regi&#xf3;n de los Apalaches del este de Kentucky.MEDIDAS DE RESULTADO PRINCIPALES: Los resultados primarios medidos fueron proporciones de encuentros de pacientes hospitalizados y de emergencia, cargo hospitalario total y duraci&#xf3;n de la estancia hospitalaria.RESULTADOS: Se identificaron 825 encuentros previos a la expansi&#xf3;n y 5726 posteriores a la expansi&#xf3;n. La posexpansi&#xf3;n demostr&#xf3; disminuciones en los no asegurados (9.2% a 1.0%, p &lt; 0.001), encuentros de pacientes hospitalizados (42.7% a 8.1%, p &lt; 0.001), admisiones de emergencia (36.7% a 12.3%, p &lt; 0,001), admisiones desde el servicio de urgencias (8.0% a 0.2%, p &lt; 0.001), la mediana de los gastos hospitalarios totales ($7080 a $3260, p &lt; 0.001) y la mediana de la estancia hospitalaria total (4 a 3 d&#xed;as, p &lt; 0.001). De manera similar, la cobertura de Medicaid (18.8% a 27.7%, p &lt; 0.001), consultas ambulatorias (57.3% a 91.9%, p &lt; 0.001), admisiones electivas (46.9% a 76.2%, p &lt; 0.001), admisiones desde la cl&#xed;nica (78.4% al 90.2%, p &lt; 0.001), y las altas domiciliarias (43.8% al 88.2%, p &lt; 0.001) aumentaron despu&#xe9;s de la expansi&#xf3;n.LIMITACIONES: Este estudio est&#xe1; sujeto a las limitaciones inherentes de ser retrospectivo y utilizar una base de datos parcialmente desidentificada.CONCLUSIONES: Este estudio es el primero en demostrar los cambios en las tendencias en la atenci&#xf3;n despu&#xe9;s de la expansi&#xf3;n de Medicaid para pacientes con enfermedad inflamatoria intestinal en el Estado de Kentucky, especialmente en los Apalaches de Kentucky, mostrando un aumento significativo en la utilizaci&#xf3;n de la atenci&#xf3;n ambulatoria, visitas reducidas al departamento de emergencias y menor duraci&#xf3;n de la estancia hospitalaria. (Traducci&#xf3;n-Dr. Jorge Silva Velazco ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>Jennifer T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Markey Cancer Center, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Brittany E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangino</LastName><ForeName>Anthony A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Hannah G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Markey Cancer Center, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAtee</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jitesh A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colorectal Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evers</LastName><ForeName>B Mark</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Markey Cancer Center, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhakta</LastName><ForeName>Avinash S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colorectal Surgery, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 CA160003</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007629" MajorTopicYN="N" Type="Geographic">Kentucky</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058991" MajorTopicYN="Y">Patient Protection and Affordable Care Act</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001061" MajorTopicYN="N" Type="Geographic">Appalachian Region</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="ANTECEDENTES:">La expansi&#xf3;n de Medicaid mejor&#xf3; la cobertura de seguro para pacientes con enfermedades cr&#xf3;nicas y bajos ingresos. Se desconoce el efecto de la expansi&#xf3;n de Medicaid en pacientes con enfermedad inflamatoria intestinal de comunidades de alta pobreza.</AbstractText><AbstractText Label="OBJETIVO:">Este estudio tuvo como objetivo evaluar el impacto de la expansi&#xf3;n de Medicaid en Kentucky en la atenci&#xf3;n de pacientes con enfermedad inflamatoria intestinal de la comunidad de los Apalaches del este de Kentucky, un &#xe1;rea hist&#xf3;ricamente empobrecida.</AbstractText><AbstractText Label="DISE&#xd1;O:">Este estudio fue un estudio retrospectivo, descriptivo, ecol&#xf3;gico.</AbstractText><AbstractText Label="CONFIGURACI&#xd3;N:">Este estudio se realiz&#xf3; en Kentucky utilizando la base de datos de servicios ambulatorios y de alta hospitalaria.</AbstractText><AbstractText Label="PACIENTES:">Se incluyeron todos los encuentros para la atenci&#xf3;n de la enfermedad inflamatoria intestinal para 2009-2020 para pacientes de la regi&#xf3;n de los Apalaches del este de Kentucky.</AbstractText><AbstractText Label="MEDIDAS DE RESULTADO PRINCIPALES:">Los resultados primarios medidos fueron proporciones de encuentros de pacientes hospitalizados y de emergencia, cargo hospitalario total y duraci&#xf3;n de la estancia hospitalaria.</AbstractText><AbstractText Label="RESULTADOS:">Se identificaron 825 encuentros previos a la expansi&#xf3;n y 5726 posteriores a la expansi&#xf3;n. La posexpansi&#xf3;n demostr&#xf3; disminuciones en los no asegurados (9,2 % a 1,0 %, p &lt; 0,001), encuentros con pacientes hospitalizados (42,7 % a 8,1 %, p &lt; 0,001), admisiones de emergencia (36,7 % a 12,3 %, p &lt; 0,001), admisiones de el servicio de urgencias (8,0 % a 0,2 %, p &lt; 0,001), la mediana de los gastos hospitalarios totales ($7080 a $3260, p &lt; 0,001) y la mediana de la estancia hospitalaria total (4 a 3 d&#xed;as, p &lt; 0,001). De manera similar, la cobertura de Medicaid (18,8 % a 27,7 %, p &lt; 0,001), consultas ambulatorias (57,3 % a 91,9 %, p &lt; 0,001), admisiones electivas (46,9 % a 76,2 %, p &lt; 0,001), admisiones desde la cl&#xed;nica (78,4 % al 90,2%, p &lt; 0,001), y las altas domiciliarias (43,8% al 88,2%, p &lt; 0,001) aumentaron despu&#xe9;s de la expansi&#xf3;n.</AbstractText><AbstractText Label="LIMITACIONES:">Este estudio est&#xe1; sujeto a las limitaciones inherentes de ser retrospectivo y utilizar una base de datos parcialmente desidentificada.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N:">Este estudio es el primero en demostrar los cambios en las tendencias en la atenci&#xf3;n despu&#xe9;s de la expansi&#xf3;n de Medicaid para pacientes con enfermedad inflamatoria intestinal en el Estado de Kentucky, especialmente en los Apalaches de Kentucky, mostrando un aumento significativo en la utilizaci&#xf3;n de la atenci&#xf3;n ambulatoria, visitas reducidas al departamento de emergencias y menor duraci&#xf3;n de la atenci&#xf3;n. cors&#xe9;.</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2023.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>19</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37399124</ArticleId><ArticleId IdType="mid">NIHMS1909130</ArticleId><ArticleId IdType="pmc">PMC10527721</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000002942</ArticleId><ArticleId IdType="pii">00003453-202309000-00019</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu F, Carlson SA, Liu Y, Greenlund KJ. Prevalence of inflammatory bowel disease among Medicare fee-for-service beneficiaries - United States, 2001-2018. MMWR Morb Mortal Wkly Rep. 2021;70:698&#x2013;701. 10.15585/mmwr.mm7019a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7019a2</ArticleId><ArticleId IdType="pmc">PMC8118152</ArticleId><ArticleId IdType="pubmed">33983913</ArticleId></ArticleIdList></Reference><Reference><Citation>Okobi OE, Udoete IO, Fasehun OO, et al. A review of four practice guidelines of inflammatory bowel disease. Cureus. 2021;13:e16859. 10.7759/cureus.16859</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.16859</ArticleId><ArticleId IdType="pmc">PMC8413108</ArticleId><ArticleId IdType="pubmed">34513436</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S; AGA Institute Clinical Guidelines Committee. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158:1450&#x2013;1461. 10.1053/j.gastro.2020.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.01.006</ArticleId><ArticleId IdType="pmc">PMC7175923</ArticleId><ArticleId IdType="pubmed">31945371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology. 2019;156:748&#x2013;764. 10.1053/j.gastro.2018.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.12.009</ArticleId><ArticleId IdType="pmc">PMC6858922</ArticleId><ArticleId IdType="pubmed">30576644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lytvyak E Sr, Sutton RT, Dieleman LA, Peerani F, Fedorak RN, Kroeker KI. Management of inflammatory bowel disease patients with clinical care pathways reduces emergency department utilization. Crohns Colitis 360. 2020;2:otaa080. 10.1093/crocol/otaa080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/crocol/otaa080</ArticleId><ArticleId IdType="pmc">PMC9802474</ArticleId><ArticleId IdType="pubmed">36777757</ArticleId></ArticleIdList></Reference><Reference><Citation>Actis GC, Pellicano R. Inflammatory bowel disease: efficient remission maintenance is crucial for cost containment. World J Gastrointest Pharmacol Ther. 2017;8:114&#x2013;119. 10.4292/wjgpt.v8.i2.114</Citation><ArticleIdList><ArticleId IdType="doi">10.4292/wjgpt.v8.i2.114</ArticleId><ArticleId IdType="pmc">PMC5421109</ArticleId><ArticleId IdType="pubmed">28533920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross JS, Bradley EH, Busch SH. Use of health care services by lower-income and higher-income uninsured adults. JAMA. 2006;295:2027&#x2013;2036. 10.1001/jama.295.17.2027</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.17.2027</ArticleId><ArticleId IdType="pubmed">16670411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lines LM, Urato M, Halpern MT, Subramanian S. Insurance Coverage and Preventive Care Among Adults. Research Triangle Park (NC): RTI Press; April 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354043</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Carlson SA, Liu Y, Greenlund KJ. Urban-rural differences in health care utilization for inflammatory bowel disease in the USA, 2017. Dig Dis Sci. 2022;67:3601&#x2013;3611. 10.1007/s10620-021-07264-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-021-07264-z</ArticleId><ArticleId IdType="pmc">PMC10478171</ArticleId><ArticleId IdType="pubmed">34633623</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Agriculture. (2023, February
24). State Data. USDA ERS &#x2013; Data Products. Retrieved March 3, 2023, from https://data.ers.usda.gov/reports.aspx?StateFIPS=21&amp;StateName=Kentucky&amp;ID=17854</Citation></Reference><Reference><Citation>Health Resources and Services Administration. (2018, December
31). List of rural counties and designated eligible tracts in metropolitan counties. Accessed September 10, 2022. https://www.hrsa.gov/sites/default/files/hrsa/rural-health/resources/forhp-eligible-areas.pdf</Citation></Reference><Reference><Citation>Appalachian Regional Commission. Health Disparities in Appalachia. Accessed September 10, 2022. https://www.arc.gov/wp-content/uploads/2020/06/Health_Disparities_in_Appalachia_August_2017.pdf</Citation></Reference><Reference><Citation>Macinko J, Starfield B, Shi L. Quantifying the health benefits of primary care physician supply in the United States. Int J Health Serv. 2007;37:111&#x2013;126. 10.2190/3431-G6T7-37M8-P224</Citation><ArticleIdList><ArticleId IdType="doi">10.2190/3431-G6T7-37M8-P224</ArticleId><ArticleId IdType="pubmed">17436988</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen GC, Sam J, Murthy SK, Kaplan GG, Tinmouth JM, LaVeist TA. Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis. 2009;15:726&#x2013;733. 10.1002/ibd.20825</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.20825</ArticleId><ArticleId IdType="pubmed">19067416</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry C, Rhudy C, Flomenhoft D, et al. Inflammatory bowel disease in Appalachia: an investigation into disparate outcomes within the state of Kentucky. Gastroenterology. 2022;162(suppl):S74&#x2013;S75. 10.1053/j.gastro.2021.12.158</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.12.158</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton MF, Keirns CC, Cunningham R, Hayward RA, Stanley R. Uninsured adults presenting to US emergency departments: assumptions vs data. JAMA. 2008;300:1914&#x2013;1924. 10.1001/jama.300.16.1914</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.300.16.1914</ArticleId><ArticleId IdType="pubmed">18940978</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott KW, Scott JW, Sabbatini AK, et al. Assessing catastrophic health expenditures among uninsured people who seek care in US hospital-based emergency departments. JAMA Health Forum. 2021;2:e214359. 10.1001/jamahealthforum.2021.4359</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2021.4359</ArticleId><ArticleId IdType="pmc">PMC8796980</ArticleId><ArticleId IdType="pubmed">35977304</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. (2005). Distribution of health payments and catastrophic expenditures Methodology / by Ke Xu. World Health Organization. Accessed September 10, 2022. https://apps.who.int/iris/handle/10665/69030</Citation></Reference><Reference><Citation>Click B, Lopez R, Arrigain S, Schold J, Regueiro M, Rizk M. Shifting cost-drivers of health care expenditures in inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:1268&#x2013;1275. 10.1093/ibd/izz256</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izz256</ArticleId><ArticleId IdType="pubmed">31671186</ArticleId></ArticleIdList></Reference><Reference><Citation>Department for Medicaid Services Monthly Membership Counts by County. Cabinet for Health and Family Services. Accessed September 10, 2022. https://chfs.ky.gov/agencies/dms/stats/KYDWMMCC072022.pdf</Citation></Reference><Reference><Citation>Pollard KJL. The Appalachian Region: A Data Overview from the 2009-2013 American Community Servey. Appalachian Regional Commission. Accessed September 10 2022. https://www.arc.gov/wp-content/uploads/2020/06/DataOverviewfrom2009-2013ACS.pdf</Citation></Reference><Reference><Citation>Pollard KJL. The Appalachian Region: A Data Overview from the 2014-2018 American Community Survey. Accessed September 10, 2022. https://www.prb.org/wp-content/uploads/2020/06/prb-arc-chartbook-2020.pdf</Citation></Reference><Reference><Citation>Benitez JA, Creel L, Jennings J. Kentucky&#x2019;s Medicaid expansion showing early promise on coverage and access to care. Health Aff (Millwood). 2016;35:528&#x2013;534. 10.1377/hlthaff.2015.1294</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.1294</ArticleId><ArticleId IdType="pubmed">26888198</ArticleId></ArticleIdList></Reference><Reference><Citation>Coverage for pre-existing conditions U.S. Centers for Medicare &amp; Medicaid Services; 
Accessed September 10 2022. https://www.healthcare.gov/coverage/pre-existing-conditions/</Citation></Reference><Reference><Citation>Whitfield E, Adler J, Gebremariam A, Davis M. Insurance among young adults with inflammatory bowel disease: changes under the Affordable Care Act dependent provision. J Pediatr Gastroenterol Nutr. 2017;64:962&#x2013;965. 10.1097/MPG.0000000000001378</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000001378</ArticleId><ArticleId IdType="pubmed">27513697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelle BA, Johnson TR, Ryan JC, et al. Fate of the uninsured ankle fracture: significant delays in treatment result in an increased risk of surgical site infection. J Orthop Trauma. 2021;35:154&#x2013;159. 10.1097/BOT.0000000000001907</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOT.0000000000001907</ArticleId><ArticleId IdType="pubmed">32947353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kentucky Inpatient Hospitalization and Outpatient Services Claims Files, Frankfort, KY, [2009-2020]; Cabinet for Health and Family Services, Office of Health Policy.</Citation></Reference><Reference><Citation>Appalachian Counties Served by ARC. Appalachian Regional Commission. Accessed April 3, 2023. https://www.arc.gov/appalachian-counties-served-by-arc/</Citation></Reference><Reference><Citation>Pollard KJL. The Appalachian Region: A Data Overview from the 2015-2019 American Community Survey. Appalachian Regional Commission. Accessed September 10, 2022. https://www.arc.gov/wp-content/uploads/2021/06/PRB_ARC_Chartbook_ACS_2015-2019_FINAL_2021-06_R1.pdf</Citation></Reference><Reference><Citation>Lazar M, Davenport L. Barriers to health care access for low income families: a review of literature. J Community Health Nurs. 2018;35:28&#x2013;37. 10.1080/07370016.2018.1404832</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07370016.2018.1404832</ArticleId><ArticleId IdType="pubmed">29323941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021;8:765474. 10.3389/fmed.2021.765474</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.765474</ArticleId><ArticleId IdType="pmc">PMC8720971</ArticleId><ArticleId IdType="pubmed">34988090</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabhajosyula S, Kumar V, Sundaragiri PR, et al. Management and outcomes of acute myocardial infarction-cardiogenic shock in uninsured compared with privately insured individuals. Circ Heart Fail. 2022;15:e008991. 10.1161/CIRCHEARTFAILURE.121.008991</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.121.008991</ArticleId><ArticleId IdType="pmc">PMC9930186</ArticleId><ArticleId IdType="pubmed">35240866</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NH, Khera R, Dulai PS, et al. National estimates of financial hardship from medical bills and cost-related medication nonadherence in patients with inflammatory bowel diseases in the United States. Inflamm Bowel Dis. 2021;27:1068&#x2013;1078. 10.1093/ibd/izaa266</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa266</ArticleId><ArticleId IdType="pmc">PMC8205631</ArticleId><ArticleId IdType="pubmed">33051681</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan T, Sinner HF, Walling SC, et al. Impact of the Affordable Care Act on colorectal cancer screening, incidence, and survival in Kentucky. J Am Coll Surg. 2019;228:342&#x2013;353.e1. 10.1016/j.jamcollsurg.2018.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2018.12.035</ArticleId><ArticleId IdType="pmc">PMC6537585</ArticleId><ArticleId IdType="pubmed">30802505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommers BD, Blendon RJ, Orav EJ. Both the &#x2018;private option&#x2019; and traditional Medicaid expansions improved access to care for low-income adults. Health Aff (Millwood). 2016;35:96&#x2013;105. 10.1377/hlthaff.2015.0917</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0917</ArticleId><ArticleId IdType="pubmed">26733706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurenko O, Balio CP, Agarwal R, Carroll AE, Menachemi N. The effects of Medicaid expansion under the ACA: a systematic review. Health Aff (Millwood). 2018;37:944&#x2013;950. 10.1377/hlthaff.2017.1491</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2017.1491</ArticleId><ArticleId IdType="pubmed">29863941</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, MacIsaac D, Wong JJ, et al. Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther. 2018;47:364&#x2013;370. 10.1111/apt.14430</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14430</ArticleId><ArticleId IdType="pmc">PMC5760274</ArticleId><ArticleId IdType="pubmed">29164650</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes EL, Jiang Y, Kappelman MD, et al. Decreasing colectomy rate for ulcerative colitis in the United States between 2007 and 2016: a time trend analysis. Inflamm Bowel Dis. 2020;26:1225&#x2013;1231. 10.1093/ibd/izz247</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izz247</ArticleId><ArticleId IdType="pmc">PMC7365804</ArticleId><ArticleId IdType="pubmed">31634390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee K, Kamal KM. Sociodemographic determinants of out-of-pocket expenditures for patients using prescription drugs for rheumatoid arthritis. Am Health Drug Benefits. 2017;10:7&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5394540</ArticleId><ArticleId IdType="pubmed">28465764</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulai PS, Osterman MT, Lasch K, Cao C, Riaz F, Sandborn WJ. Market access analysis of biologics and small-molecule inhibitors for inflammatory bowel disease among US health insurance policies. Dig Dis Sci. 2019;64:2478&#x2013;2488. 10.1007/s10620-019-05594-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-019-05594-7</ArticleId><ArticleId IdType="pmc">PMC6704097</ArticleId><ArticleId IdType="pubmed">30923985</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36064285</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5808</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Neurologia</Title><ISOAbbreviation>Neurologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Headache: what to ask, how to examine, and what scales to use. Recommendations of the Spanish society of neurology's headache study group.</ArticleTitle><Pagination><StartPage>564</StartPage><EndPage>574</EndPage><MedlinePgn>564-574</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nrleng.2018.12.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5808(21)00013-4</ELocationID><Abstract><AbstractText>INTRODUCCI&#xf3;N: La cefalea es el motivo de consulta neurol&#xf3;gico m&#xe1;s prevalente en los distintos niveles asistenciales, donde la anamnesis y exploraci&#xf3;n son primordiales para realizar un diagn&#xf3;stico y tratamiento adecuados. Con la intenci&#xf3;n de unificar la atenci&#xf3;n de esta patolog&#xed;a, el Grupo de Estudio de Cefalea de la Sociedad Espa&#xf1;ola de Neurolog&#xed;a (GECSEN) ha decidido elaborar unas recomendaciones consensuadas para mejorar y garantizar una adecuada asistencia en Atenci&#xf3;n Primaria, Urgencias y Neurolog&#xed;a. METODOLOG&#xed;A: El documento es pr&#xe1;ctico, sigue el orden de la din&#xe1;mica de actuaci&#xf3;n durante una consulta: anamnesis, escalas que cuantifican el impacto y la discapacidad y exploraci&#xf3;n. Adem&#xe1;s, finaliza con pautas para realizar un seguimiento adecuado y un manejo de las expectativas del paciente con el tratamiento pautado. CONCLUSIONES: Esperamos ofrecer una herramienta que mejore la atenci&#xf3;n al paciente con cefalea para garantizar una asistencia adecuada y homog&#xe9;nea a nivel nacional.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Sociedad Espa&#xf1;ola de Neurolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gago-Veiga</LastName><ForeName>A B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain. Electronic address: dra.anagago@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cami&#xf1;a Mu&#xf1;iz</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Cl&#xed;nica Rotger y Hospital Quir&#xf3;nsalud Palmaplanas, Grupo Quir&#xf3;nsalud, Palma de Mallorca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Azor&#xed;n</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a. Hospital Cl&#xed;nico Universitario de Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Quintanilla</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Universitario Marqu&#xe9;s de Valdecilla, Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ord&#xe1;s</LastName><ForeName>C M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a - Hospital Universitario Rey Juan Carlos, M&#xf3;stoles, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Ferrus</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad de Cefalea, Servicio de Neurolog&#xed;a, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Grupo de Investigaci&#xf3;n en Cefalea, VHIR, Universitat Aut&#xf2;noma Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Lasaosa</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario Lozano Blesa, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viguera-Romero</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad Gesti&#xf3;n Cl&#xed;nica de Neurolog&#xed;a, Hospital Virgen Macarena, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozo-Rosich</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unidad de Cefalea, Servicio de Neurolog&#xed;a, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Grupo de Investigaci&#xf3;n en Cefalea, VHIR, Universitat Aut&#xf2;noma Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Neurologia (Engl Ed)</MedlineTA><NlmUniqueID>101778590</NlmUniqueID><ISSNLinking>2173-5808</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="Y">Headache</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009462" MajorTopicYN="Y">Neurology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anamnesis</Keyword><Keyword MajorTopicYN="N">Calendar</Keyword><Keyword MajorTopicYN="N">Calendario</Keyword><Keyword MajorTopicYN="N">Cefalea</Keyword><Keyword MajorTopicYN="N">Clinical history</Keyword><Keyword MajorTopicYN="N">Diario electr&#xf3;nico</Keyword><Keyword MajorTopicYN="N">Educaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Education</Keyword><Keyword MajorTopicYN="N">Electronic diary</Keyword><Keyword MajorTopicYN="N">Escalas</Keyword><Keyword MajorTopicYN="N">Examination</Keyword><Keyword MajorTopicYN="N">Exploraci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Scales</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>5</Day><Hour>21</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36064285</ArticleId><ArticleId IdType="doi">10.1016/j.nrleng.2018.12.016</ArticleId><ArticleId IdType="pii">S2173-5808(21)00013-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33941054</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2171-8695</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria</Title><ISOAbbreviation>Farm Hosp</ISOAbbreviation></Journal><ArticleTitle>Estudio multic&#xe9;ntrico de la incidencia y evitabilidad de los incidentes por medicamentos en pacientes que acuden a los servicios de urgencias pedi&#xe1;tricas.</ArticleTitle><Pagination><StartPage>115</StartPage><EndPage>120</EndPage><MedlinePgn>115-120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7399/fh.11583</ELocationID><Abstract><AbstractText>Objetivo: Determinar la incidencia, gravedad y evitabilidad de los&#xa0; incidentes&#xa0;por medicamentos detectados en los pacientes que acuden a los&#xa0;servicios de urgencias pedi&#xe1;tricas, e identificar los grupos de edad de&#xa0;mayor riesgo y los medicamentos implicados.M&#xe9;todo: Estudio multic&#xe9;ntrico observacional prospectivo, realizado&#xa0;entre&#xa0; marzo y junio de 2017, en pacientes entre 0 y 16 a&#xf1;os que acudieron&#xa0;a los servicios de urgencias pedi&#xe1;tricas de ocho hospitales p&#xfa;blicos&#xa0;espa&#xf1;oles. Se recogieron tres tipos de incidentes: eventos adversos por&#xa0;medicamentos, errores de medicaci&#xf3;n e intoxicaciones accidentales. Los&#xa0;incidentes se caracterizaron atendiendo a su gravedad, evitabilidad, grupos&#xa0;de edad afectados y medicamentos implicados.Resultados: Durante el periodo de estudio se registraron 99.797 visitas&#xa0;a los servicios de urgencias pedi&#xe1;tricas y se recogieron 334 incidentes por&#xa0;medicamentos en 334 pacientes, de los cuales el 52,4% fueron varones,&#xa0;con una media de edad de 47,1 &#xb1; 44,4 meses. La incidencia de pacientes&#xa0; con incidentes fue del 0,3%. Del total de incidentes, 264 (79%) fueron considerados prevenibles y 158 (47,3%) produjeron da&#xf1;o a los pacientes. Los incidentes detectados fueron 144 (43,1%) eventos adversos por medicamentos, 218 (65,2%) errores de medicaci&#xf3;n (74 de ellos errores con da&#xf1;o, que se incluyen asimismo como eventos adversos prevenibles) y 46 (13,7%) intoxicaciones accidentales. Los preescolares (edad: 1-5 a&#xf1;os) presentaron el 60,8% de los incidentes, siendo tambi&#xe9;n el grupo de edad con un mayor porcentaje de incidentes prevenibles (64%). Un total de 351 medicamentos estuvieron implicados en los incidentes y pertenecieron mayoritariamente a tres grupos terap&#xe9;uticos: antiinfecciosos de uso sist&#xe9;mico (171; 48,7%), sistema nervioso (66; 18,8%) y sistema respiratorio (41; 11,7%).Conclusiones: La incidencia de incidentes por medicamentos en los&#xa0;pacientes pedi&#xe1;tricos que acudieron a servicios de urgencias fue inferior&#xa0;a la referida en pacientes adultos, si bien pr&#xe1;cticamente la mitad de los&#xa0;incidentes detectados causaron da&#xf1;os a los pacientes. Los ni&#xf1;os preescolares&#xa0;(1-5 a&#xf1;os) fueron identificados como el grupo de edad con mayor&#xa0;riesgo. Los incidentes registrados estuvieron causados por un n&#xfa;mero&#xa0;reducido de medicamentos. Un elevado porcentaje de los incidentes fueron&#xa0;prevenibles, lo que confirma la imperiosa necesidad de implementar&#xa0;medidas de prevenci&#xf3;n de incidentes en esta poblaci&#xf3;n.</AbstractText><CopyrightInformation>Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garrido-Corro</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Hospital Cl&#xed;nico Universitario Virgen de la Arrixaca, Murcia. Espa&#xf1;a.. garrido.beatriz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Llamazares</LastName><ForeName>Cecilia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid. Espa&#xf1;a.. Cecilia.martinez@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Marrod&#xe1;n</LastName><ForeName>Bel&#xe9;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid. Espa&#xf1;a.. belenrodma@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozas</LastName><ForeName>Maite</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Hospital Infantil Universitario Ni&#xf1;o Jes&#xfa;s, Madrid. Espa&#xf1;a.. maite.pozas@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solano-Navarro</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Hospital Cl&#xed;nico Universitario Virgen de la Arrixaca, Murcia. Espa&#xf1;a.. carsolna@yahoo.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otero</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Pharmacy Department, ISMP-Espa&#xf1;a. Hospital Universitario de Salamanca-IBSAL, Salamanca. Espa&#xf1;a.. MJOTERO@telefonica.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Estudio multic&#xe9;ntrico de la incidencia y evitabilidad de los incidentes por medicamentos en pacientes que acuden a los servicios de urgencias pedi&#xe1;tricas.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Farm Hosp</MedlineTA><NlmUniqueID>9440679</NlmUniqueID><ISSNLinking>1130-6343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Objetivo: Determinar la incidencia, gravedad y evitabilidad de los&#xa0; incidentes&#xa0;por medicamentos detectados en los pacientes que acuden a los&#xa0;servicios de urgencias pedi&#xe1;tricas, e identificar los grupos de edad de&#xa0;mayor riesgo y los medicamentos implicados.M&#xe9;todo: Estudio multic&#xe9;ntrico observacional prospectivo, realizado&#xa0;entre&#xa0; marzo y junio de 2017, en pacientes entre 0 y 16 a&#xf1;os que acudieron&#xa0;a los servicios de urgencias pedi&#xe1;tricas de ocho hospitales p&#xfa;blicos&#xa0;espa&#xf1;oles. Se recogieron tres tipos de incidentes: eventos adversos por&#xa0;medicamentos, errores de medicaci&#xf3;n e intoxicaciones accidentales. Los&#xa0;incidentes se caracterizaron atendiendo a su gravedad, evitabilidad, grupos&#xa0;de edad afectados y medicamentos implicados.Resultados: Durante el periodo de estudio se registraron 99.797 visitas&#xa0;a los servicios de urgencias pedi&#xe1;tricas y se recogieron 334 incidentes por&#xa0;medicamentos en 334 pacientes, de los cuales el 52,4% fueron varones,&#xa0;con una media de edad de 47,1 &#xb1; 44,4 meses. La incidencia de pacientes&#xa0; con incidentes fue del 0,3%. Del total de incidentes, 264 (79%) fueron considerados prevenibles y 158 (47,3%) produjeron da&#xf1;o a los pacientes. Los incidentes detectados fueron 144 (43,1%) eventos adversos por medicamentos, 218 (65,2%) errores de medicaci&#xf3;n (74 de ellos errores con da&#xf1;o, que se incluyen asimismo como eventos adversos prevenibles) y 46 (13,7%) intoxicaciones accidentales. Los preescolares (edad: 1-5 a&#xf1;os) presentaron el 60,8% de los incidentes, siendo tambi&#xe9;n el grupo de edad con un mayor porcentaje de incidentes prevenibles (64%). Un total de 351 medicamentos estuvieron implicados en los incidentes y pertenecieron mayoritariamente a tres grupos terap&#xe9;uticos: antiinfecciosos de uso sist&#xe9;mico (171; 48,7%), sistema nervioso (66; 18,8%) y sistema respiratorio (41; 11,7%).Conclusiones: La incidencia de incidentes por medicamentos en los&#xa0;pacientes pedi&#xe1;tricos que acudieron a servicios de urgencias fue inferior&#xa0;a la referida en pacientes adultos, si bien pr&#xe1;cticamente la mitad de los&#xa0;incidentes detectados causaron da&#xf1;os a los pacientes. Los ni&#xf1;os preescolares&#xa0;(1-5 a&#xf1;os) fueron identificados como el grupo de edad con mayor&#xa0;riesgo. Los incidentes registrados estuvieron causados por un n&#xfa;mero&#xa0;reducido de medicamentos. Un elevado porcentaje de los incidentes fueron&#xa0;prevenibles, lo que confirma la imperiosa necesidad de implementar&#xa0;medidas de prevenci&#xf3;n de incidentes en esta poblaci&#xf3;n.</AbstractText><CopyrightInformation>Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>4</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33941054</ArticleId><ArticleId IdType="doi">10.7399/fh.11583</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33867521</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2173-9110</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2021</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Revista espanola de salud publica</Title><ISOAbbreviation>Rev Esp Salud Publica</ISOAbbreviation></Journal><ArticleTitle>[Who is in the Hospital Emergency Department? Descriptive study of the variability of specialties in the Emergency Department.].</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e202104055</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Giving the absence of specialized training to work as a physician in the Emergency Department in Spain, the aim of the study was to describe the variability of specialties in these departments nationally, by regions and hospital complexity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A descriptive cross-sectional study was carried out through a survey addressed to Emergency Chiefs of Spanish public hospitals, 65 of whom answered between January 2018 and September 2019. Descriptive and correlative analyzes of the variables were performed, assuming those with p&lt;0.05 as statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">1,706 emergency physicians of 29 different specialties were described, of which 1,336 (78.31%) were Family and Community Medicine specialists. Different number of specialties among regions and hospitals of different complexities were described. 98.46% of surveyed chiefs demanded specialized formation on Emergency Medicine. Direct correlations were found between the complexity of the hospital and the number of specialties in the Emergency Department (r=0.2921, CI: 0.04445-0.5059; p&lt;0.05); the complexity of the hospital and the number of emergency physicians (r=0.69, CI: 0.5310-0.8020; p&lt;0.0001), as well as between the number of emergency physicians and the number of different specialties in the Emergency Department (r=0.3901, CI: 0.1543-0.5838; p&lt;0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Physicians of 29 different specialties were described working in the Emergency Departments. The variability of specialties changed among regions and hospitals of different complexities. Heads of Emergency Departments agreed on the need for specialized formation on Emergency Medicine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Plaza</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Facultad de Medicina. Universidad de Navarra. Pamplona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galofr&#xe9;</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Departamento de Endocrinolog&#xed;a y Nutrici&#xf3;n. Cl&#xed;nica Universidad de Navarra. Pamplona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>&#xbf;Qui&#xe9;n est&#xe1; en los servicios de urgencias hospitalarias? Estudio descriptivo de la variabilidad de especialidades en urgencias.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Salud Publica</MedlineTA><NlmUniqueID>9600212</NlmUniqueID><ISSNLinking>1135-5727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004635" MajorTopicYN="N">Emergency Medicine</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006779" MajorTopicYN="N">Hospitals, Public</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013038" MajorTopicYN="N">Specialization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Ante la ausencia de una formaci&#xf3;n especializada para trabajar de m&#xe9;dico adjunto en los Servicios de Urgencias Hospitalarios espa&#xf1;oles, se busc&#xf3; describir la variabilidad de especialidades de los m&#xe9;dicos adjuntos en estos servicios a nivel nacional, por Comunidades Aut&#xf3;nomas y complejidad del hospital.</AbstractText><AbstractText Label="METODOS" NlmCategory="METHODS">Se realiz&#xf3; un estudio descriptivo transversal a trav&#xe9;s de una encuesta estructurada dirigida a los responsables de Servicios de Urgencias Hospitalarias p&#xfa;blicos espa&#xf1;oles, de los que contestaron 65 entre enero del 2018 y septiembre del 2019. Se elabor&#xf3; un an&#xe1;lisis descriptivo y correlacional de las variables, asumiendo valores estad&#xed;sticamente significativos aquellos con una p&lt;0,05.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Se describieron 1.706 m&#xe9;dicos de urgencias, distribuidos en 29 especialidades diferentes, de los cuales 1.336 (78,31%) eran especialistas en Medicina de Familia y Comunitaria. Se encontraron diferente n&#xfa;mero de especialidades entre Comunidades Aut&#xf3;nomas y hospitales de distintas complejidades, y el 98,46% de los encuestados solicitaron una formaci&#xf3;n especializada en Medicina de Urgencias y Emergencias. Se hallaron correlaciones directas entre la complejidad del hospital y el n&#xfa;mero de especialidades en urgencias (r=0,2921, IC: 0,04445-0,5059) p&lt;0,05; entre la complejidad del hospital y el n&#xfa;mero de adjuntos en urgencias (r=0,69, IC: 0,5310-0,8020) p&lt;0,0001; y entre el n&#xfa;mero de adjuntos por servicio y su n&#xfa;mero de especialidades diferentes (r=0,3901, IC: 0,1543-0,5838) p&lt;0,005.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Se describieron m&#xe9;dicos de 29 especialidades diferentes trabajando en urgencias. La variabilidad de especialidades difer&#xed;a entre Comunidades Aut&#xf3;nomas y hospitales de distinta complejidad. Los responsables de urgencias coincid&#xed;an en la necesidad de una formaci&#xf3;n especializada en Medicina de Urgencias y Emergencias.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emergency medicine</Keyword><Keyword MajorTopicYN="N">Emergency service</Keyword><Keyword MajorTopicYN="N">Hospital</Keyword><Keyword MajorTopicYN="N">Medical specialties</Keyword><Keyword MajorTopicYN="N">Spain</Keyword></KeywordList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33867521</ArticleId><ArticleId IdType="pii">e202104055</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>